KEGG   DRUG: alpha 1-Antitrypsin
Entry
D11965                      Drug                                   
Name
alpha 1-Antitrypsin;
Human alpha 1-Proteinase inibitor, freeze-dried concentrated;
Lynspad (TN)
Remark
Therapeutic category: 6343
ATC code: B02AB02
Product: D11965<JP>
Efficacy
Elastase inhibitor
Target
SERPINA1 [HSA:5265] [KO:K03984]
  Pathway
hsa04610  Complement and coagulation cascades
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02A ANTIFIBRINOLYTICS
    B02AB Proteinase inhibitors
     B02AB02 alfa1 Antitrypsin
      D11965  alpha 1-Antitrypsin <JP>
USP drug classification [BR:br08302]
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
  Alpha 1-proteinase Inhibitor, Human
   D11965  alpha 1-Antitrypsin
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   634  Human blood preparations
    6343  Plasma preparations
     D11965  alpha 1-Antitrypsin
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    SERPINA1
     D11965  alpha 1-Antitrypsin <JP>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11965
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11965
Other DBs
CAS: 9041-92-3
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system